These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 25606783)
1. Pretransplant malignancy as a risk factor for posttransplant malignancy after heart transplantation. Yoosabai A; Mehta A; Kang W; Chaiwatcharayut W; Sampaio M; Huang E; Bunnapradist S Transplantation; 2015 Feb; 99(2):345-50. PubMed ID: 25606783 [TBL] [Abstract][Full Text] [Related]
2. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients. Kang W; Sampaio MS; Huang E; Bunnapradist S Transplantation; 2017 Jun; 101(6):1303-1309. PubMed ID: 27336396 [TBL] [Abstract][Full Text] [Related]
3. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. Garrett GL; Blanc PD; Boscardin J; Lloyd AA; Ahmed RL; Anthony T; Bibee K; Breithaupt A; Cannon J; Chen A; Cheng JY; Chiesa-Fuxench Z; Colegio OR; Curiel-Lewandrowski C; Del Guzzo CA; Disse M; Dowd M; Eilers R; Ortiz AE; Morris C; Golden SK; Graves MS; Griffin JR; Hopkins RS; Huang CC; Bae GH; Jambusaria A; Jennings TA; Jiang SI; Karia PS; Khetarpal S; Kim C; Klintmalm G; Konicke K; Koyfman SA; Lam C; Lee P; Leitenberger JJ; Loh T; Lowenstein S; Madankumar R; Moreau JF; Nijhawan RI; Ochoa S; Olasz EB; Otchere E; Otley C; Oulton J; Patel PH; Patel VA; Prabhu AV; Pugliano-Mauro M; Schmults CD; Schram S; Shih AF; Shin T; Soon S; Soriano T; Srivastava D; Stein JA; Sternhell-Blackwell K; Taylor S; Vidimos A; Wu P; Zajdel N; Zelac D; Arron ST JAMA Dermatol; 2017 Mar; 153(3):296-303. PubMed ID: 28097368 [TBL] [Abstract][Full Text] [Related]
4. Pretransplant malignancy among lung transplant recipients in the modern era. Rudasill SE; Iyengar A; Sanaiha Y; Khoury H; Mardock AL; Xing H; Kwon MH; Hunter C; Benharash P Surgery; 2019 Jun; 165(6):1228-1233. PubMed ID: 30827490 [TBL] [Abstract][Full Text] [Related]
5. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer. Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250 [TBL] [Abstract][Full Text] [Related]
6. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan. Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940 [TBL] [Abstract][Full Text] [Related]
7. Incidence and Risk Factors of Keratinocyte Carcinoma After First Solid Organ Transplant in Ontario, Canada. Park CK; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Rochon PA; Chan AW JAMA Dermatol; 2019 Sep; 155(9):1041-1048. PubMed ID: 31116351 [TBL] [Abstract][Full Text] [Related]
8. Skin cancer outcomes and risk factors in renal transplant recipients: Analysis of organ procurement and transplantation network data from 2000 to 2021. Hao X; Lai W; Xia X; Xu J; Wu Y; Lv C; Meng Q; Lv K; Huang S; Luo Z; Dong J; Yuan Q Front Oncol; 2022; 12():1017498. PubMed ID: 36505816 [TBL] [Abstract][Full Text] [Related]
9. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Sampaio MS; Cho YW; Qazi Y; Bunnapradist S; Hutchinson IV; Shah T Transplantation; 2012 Nov; 94(10):990-8. PubMed ID: 23085553 [TBL] [Abstract][Full Text] [Related]
10. Mortality among solid organ transplant recipients with a pretransplant cancer diagnosis. Hart A; Pfeiffer RM; Morawski BM; Lynch CF; Zeng Y; Pawlish K; Hurley D; Yu KJ; Engels EA Am J Transplant; 2023 Feb; 23(2):257-264. PubMed ID: 36804133 [TBL] [Abstract][Full Text] [Related]
11. Malignancy after heart transplantation: analysis of 24-year experience at a single center. Yagdi T; Sharples L; Tsui S; Large S; Parameshwar J J Card Surg; 2009; 24(5):572-9. PubMed ID: 19486222 [TBL] [Abstract][Full Text] [Related]
12. Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. Otley CC; Cherikh WS; Salasche SJ; McBride MA; Christenson LJ; Kauffman HM J Am Acad Dermatol; 2005 Nov; 53(5):783-90. PubMed ID: 16243126 [TBL] [Abstract][Full Text] [Related]
13. Association of Size Matching Using Predicted Heart Mass With Mortality in Heart Transplant Recipients With Obesity or High Pulmonary Vascular Resistance. Tao R; Hess TM; Kuchnia A; Hermsen J; Raza F; Dhingra R JAMA Netw Open; 2023 Jun; 6(6):e2319191. PubMed ID: 37351886 [TBL] [Abstract][Full Text] [Related]
14. Characterization of de novo malignancy after orthotopic heart transplantation: single-centre outcomes over 20 years. Bakir NH; Florea IB; Phillipps J; Schilling JD; Damiano MS; Ewald GA; Kotkar KD; Itoh A; Damiano RJ; Moon MR; Masood MF Eur J Cardiothorac Surg; 2023 Oct; 64(4):. PubMed ID: 37815836 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of Solid Organ Transplant Recipients With Preexisting Malignancies in Remission: A Systematic Review and Meta-Analysis. Acuna SA; Huang JW; Daly C; Shah PS; Kim SJ; Baxter NN Transplantation; 2017 Mar; 101(3):471-481. PubMed ID: 27101077 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for development of new-onset diabetes mellitus in adult heart transplant recipients. Ye X; Kuo HT; Sampaio MS; Jiang Y; Reddy P; Bunnapradist S Transplantation; 2010 Jun; 89(12):1526-32. PubMed ID: 20431437 [TBL] [Abstract][Full Text] [Related]
17. Impact of Pretransplant Malignancy on Heart Transplantation Outcomes: Contemporary United Network for Organ Sharing Analysis Amidst Evolving Cancer Therapies. Batra J; DeFilippis EM; Golob S; Clerkin K; Topkara VK; Habal MV; Restaino S; Griffin J; Hi Lee S; Latif F; Farr MA; Sayer G; Raikelkar J; Uriel N Circ Heart Fail; 2022 Apr; 15(4):e008968. PubMed ID: 35094567 [TBL] [Abstract][Full Text] [Related]
18. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma. Zwald FO; Sargen MR; Austin AA; Hsieh MC; Pawlish K; Li J; Lynch CF; Yu KJ; Engels EA Am J Transplant; 2024 Jun; 24(6):993-1002. PubMed ID: 38387619 [TBL] [Abstract][Full Text] [Related]
19. Prescription opioid use before and after heart transplant: Associations with posttransplant outcomes. Lentine KL; Shah KS; Kobashigawa JA; Xiao H; Zhang Z; Axelrod DA; Lam NN; Segev DL; McAdams-DeMarco MA; Randall H; Hess GP; Yuan H; Vest LS; Kasiske BL; Schnitzler MA Am J Transplant; 2019 Dec; 19(12):3405-3414. PubMed ID: 31397964 [TBL] [Abstract][Full Text] [Related]
20. Pretransplant Cancer in Kidney Recipients in Relation to Recurrent and De Novo Cancer Incidence Posttransplantation and Implications for Graft and Patient Survival. Unterrainer C; Opelz G; Döhler B; Süsal C; Transplantation; 2019 Mar; 103(3):581-587. PubMed ID: 30418430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]